naproxen has been researched along with Body Weight in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordish-Dressman, H; Miglietta, D; Miller, BK; Nagaraju, K; Ongini, E; Phadke, A; Quinn, JL; Tatem, KS; Uaesoontrachoon, K; Van Der Meulen, JH; Yu, Q | 1 |
| Dutta, G; Ghosh, T; Goswami, AR; Sil, S | 1 |
| Hooker, AC; Kokki, H; Kokki, M; Kumpulainen, E; Lehtonen, M; Manner, M; Ranta, VP; Välitalo, P | 1 |
| Hendriks, T; Lomme, RM; van der Vijver, RJ; van Laarhoven, CJ | 1 |
| Brune, K; Gertz, BJ; Gottesdiener, KM; Holmes, GB; Kalyani, RN; Lasseter, KC; Laurenzi, M; Malice, MP; Redfern, KJ; Schwartz, JI; Vandormael, K | 1 |
| Curi, R; Fabrício, VE; Fernandes, LC; Fernandez, R; Folador, A; Gobbo-Bordon, D; Hirabara, SM; Jakobi, S; Moretto, KD; Piffar, PM; Pinto, GJ; Rohn, TV; Tchaikovski, O; Tosta, E | 1 |
| Aikawa, J; Bonato, SJ; Curi, R; de Oliveira, HH; Facin, M; Fernandes, LC; Fernandez, R; Ferraz, AC; Folador, A; Grohs, H; Naliwaiko, K; Nishiyama, A; Pinto, JA; Pizato, N; Yamazaki, RK | 1 |
| Gertz, BJ; Gottesdiener, KM; Hilliard, DA; Hreniuk, D; Lasseter, KC; Miller, J; Schwartz, JI; Snyder, KM; Thach, C | 1 |
| Klicius, J; Martel, RR; Metcalf, G; Rona, GA | 1 |
| Lee, KT; Lee, WM; Reiner, JM | 1 |
| Abate, MA; D'Alessandri, R; Layne, RD; Neely, JL | 1 |
| Day, R; Goodfriend, TL; Hiatt, JG; Kochar, M; Schuna, AA; Vejraska, BD | 1 |
| Goodman, LA; Pisko, EJ; Rice, D; Strader, K; White, R | 1 |
| Rugstad, HE | 1 |
6 trial(s) available for naproxen and Body Weight
| Article | Year |
|---|---|
Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Celecoxib; Creatinine; Cyclooxygenase Inhibitors; Diet; Double-Blind Method; Electrolytes; Female; Humans; Kidney; Lactones; Male; Middle Aged; Naproxen; Potassium; Pyrazoles; Sodium; Sodium Chloride, Dietary; Sulfonamides; Sulfones | 2002 |
Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Body Weight; Celecoxib; Constipation; Creatinine; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Electrolytes; Etoricoxib; Female; Headache; Humans; Male; Middle Aged; Naproxen; Potassium; Prostaglandins; Pyrazoles; Pyridines; Sodium; Sulfonamides; Sulfones; Thromboxane B2 | 2007 |
Effect of naproxen and sulindac on blood pressure response to atenolol.
Topics: Adult; Aged; Atenolol; Blood Pressure; Body Weight; Double-Blind Method; Drug Interactions; Female; Humans; Hypertension; Male; Middle Aged; Naproxen; Sulindac | 1990 |
Lack of interaction between sulindac or naproxen and propranolol in hypertensive patients.
Topics: Blood Pressure; Blood Urea Nitrogen; Body Weight; Clinical Trials as Topic; Creatinine; Drug Interactions; Humans; Hypertension; Indenes; Middle Aged; Naproxen; Potassium; Propranolol; Pulse; Random Allocation; Renin; Sodium; Sulindac | 1989 |
A 6-month, double-blind study comparing nabumetone to naproxen in the treatment of osteoarthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Body Weight; Butanones; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Nabumetone; Naproxen; Osteoarthritis; Random Allocation | 1987 |
The Norway study: plasma concentrations, efficacy, and adverse events.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Body Weight; Clinical Trials as Topic; Female; Gastrointestinal Hemorrhage; Heart Failure; Humans; Male; Middle Aged; Naproxen; Norway; Osteoarthritis; Peptic Ulcer; Piroxicam; Sex Factors | 1986 |
8 other study(ies) available for naproxen and Body Weight
| Article | Year |
|---|---|
Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Function Tests; Hindlimb; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Naproxen; Nitric Oxide Donors; Prednisolone | 2014 |
Effects of naproxen on immune responses in a colchicine-induced rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Brain; Colchicine; Cytokines; Disease Models, Animal; Hydrocortisone; Lymphocytes; Male; Naproxen; Nitrites; Phagocytes; Plaque, Amyloid; Rats; Reactive Oxygen Species; Spleen; Time Factors; Tubulin Modulators | 2014 |
Plasma and cerebrospinal fluid pharmacokinetics of naproxen in children.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Models, Biological; Naproxen | 2012 |
Diclofenac causes more leakage than naproxen in anastomoses in the small intestine of the rat.
Topics: Anastomosis, Surgical; Anastomotic Leak; Animals; Body Weight; Diclofenac; Hydroxyproline; Ileum; Intestine, Small; Male; Naproxen; Pressure; Rats; Rats, Wistar; Wounds and Injuries | 2013 |
Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats.
Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Body Weight; Cachexia; Carcinoma 256, Walker; Clenbuterol; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Eating; Energy Intake; Glycogen; Insulin; Kidney; Liver; Muscle, Skeletal; Naproxen; Rats; Rats, Wistar | 2003 |
Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats.
Topics: Animals; Body Weight; Cachexia; Carcinoma 256, Walker; Clenbuterol; Female; Fish Oils; Insulin; Naproxen; Rats; Rats, Wistar | 2004 |
Comparative effects of long term treatment with etodolac, naproxen and ibuprofen on articular and bone changes associated with adjuvant arthritis in rats.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Body Weight; Bone and Bones; Cartilage, Articular; Etodolac; Ibuprofen; Naproxen; Radiography; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Effects of naproxen and methotrexate on the extent of aortic lesions and cholesterol concentrations in cholesterol-fed rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Body Weight; Cell Division; Cholesterol; Diet, Atherogenic; Male; Methotrexate; Naproxen; Rabbits | 1980 |